Bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+))
C34H26N6O4Pt2 — CID 139142621
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+))
Bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+)) (PubChem CID 139142621) has the molecular formula C34H26N6O4Pt2 and a molecular weight of 972.78 g/mol. Its IUPAC name is bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+)).
Molecular Properties
| Compound Name | Bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+)) |
|---|---|
| PubChem CID | 139142621 |
| Molecular Formula | C34H26N6O4Pt2 |
| Molecular Weight | 972.78 g/mol |
| Exact Mass | 972.13 |
| IUPAC Name | bis(benzene-1,2-diolate);bis(phenyl(pyridin-2-yl)diazene);bis(platinum(2+)) |
| SMILES | [O-]c1ccccc1[O-].[O-]c1ccccc1[O-].[Pt+2].[Pt+2].c1ccc(/N=N/c2ccccn2)cc1.c1ccc(/N=N/c2ccccn2)cc1 |
| InChI | InChI=1S/2C11H9N3.2C6H6O2.2Pt/c2*1-2-6-10(7-3-1)13-14-11-8-4-5-9-12-11;2*7-5-3-1-2-4-6(5)8;;/h2*1-9H;2*1-4,7-8H;;/q;;;;2*+2/p-4/b2*14-13+;;;; |
| InChIKey | KRAWJBUXLXQIGW-ZRVBCOBJSA-J |
| XLogP | 6.66 |
| TPSA | 167.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 972.78 |
| LogP ≤ 5 | 6.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139142621 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.